Galectin-3, a β-galactoside-binding protein, is known to be involved in multiple roles in cancer development and progression including tumor cell growth, adhesion, angiogenesis, invasion, anti-apoptosis, and metastasis [49,50,51,52]. This evidence concerns the gene LGALS3 and cancer.